TherapeuticsMD (FRA:29TA) Quality Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:29TA TherapeuticsMD Inc FRA:29TA
48 GF Score
Price €1.69
GF Value €1.80
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is TherapeuticsMD Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

TherapeuticsMD Quality Rank Related Terms

FRA:29TA
48GF Score
TherapeuticsMD Inc FRA:29TA
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is TherapeuticsMD (FRA:29TA) Overvalued in 2026?

Based on GuruFocus' analysis, TherapeuticsMD stock appears to be undervalued. The current stock price of €1.69 is trading 6.1% below its estimated GF Value™ of €1.80. GuruFocus considers TherapeuticsMD to be Fairly Valued.

Key valuation signals for FRA:29TA:

  • Quality Rank:
  • GF Value™: €1.80 vs. price of €1.69 (6.1% below fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the FRA:29TA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TherapeuticsMD Business Description

Other Exchanges TXMD:USA
Address 951 Yamato Road, Suite 220, Boca Raton, FL, USA, 33431
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.
48GF Score

Get the complete analysis for FRA:29TA

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.69
Price
€1.80
GF Value